Diagnostic Significance and Workup
This peripheral blood smear pattern—showing elliptocytes, anisocytosis, microcytosis, polychromasia, and hypochromia—most strongly suggests iron deficiency anemia (IDA), which requires immediate investigation for gastrointestinal blood loss and potential malignancy, followed by iron replacement therapy.
Blood Smear Interpretation
The combination of microcytosis and hypochromia is the hallmark of iron deficiency, representing inadequate hemoglobin synthesis 1. Polychromasia (indicating reticulocytosis) reflects the bone marrow's compensatory response to anemia. Anisocytosis (variation in red cell size) is expected as the marrow produces both iron-deficient microcytes and larger polychromatophilic cells simultaneously 2.
Elliptocytes are less specific but can appear in iron deficiency, though their presence should also raise consideration of hereditary elliptocytosis if present in high numbers (>25% of cells) 3. However, in the context of microcytosis and hypochromia, iron deficiency remains the primary diagnosis.
Immediate Laboratory Workup
Order serum ferritin first—this is the single most useful test 1:
- Ferritin <15 μg/L: Confirms iron deficiency (99% specificity)
- Ferritin <45 μg/L: Highly suggestive of iron deficiency (92% specificity), especially with inflammation
- Ferritin >150 μg/L: Essentially excludes absolute iron deficiency
If ferritin is equivocal (15-45 μg/L), add:
- Transferrin saturation (TSAT)
- Total iron-binding capacity (TIBC)
- Serum iron
Mean corpuscular hemoglobin (MCH) is more reliable than MCV for detecting iron deficiency, as it's less affected by storage conditions and counting machines 1.
Critical Differential Diagnosis
Before proceeding with iron therapy, exclude thalassemia trait if 4, 1, 5:
- MCV is disproportionately low relative to degree of anemia
- Patient has appropriate ethnic background (Mediterranean, Asian, African descent)
- Ferritin is normal
Order hemoglobin electrophoresis in these cases—elevated HbA2 confirms β-thalassemia trait 5.
The key distinction: In iron deficiency, hypochromic cells outnumber microcytes; in β-thalassemia trait, microcytes outnumber hypochromic cells 6. The microcytic-hypochromic ratio <0.9 has 94% sensitivity and 92% specificity for iron-deficient erythropoiesis 6.
Source Investigation (Critical for Mortality Prevention)
Once iron deficiency is confirmed, assume gastrointestinal blood loss until proven otherwise 1. This is essential because:
- GI malignancy must be excluded, particularly colorectal cancer
- Investigation is warranted at any level of anemia with iron deficiency, though urgency increases with severity 1
- Men with Hb <110 g/L or non-menstruating women with Hb <100 g/L require fast-track referral 1
Specific investigations needed:
- Upper endoscopy and colonoscopy for adults
- Stool for occult blood (though negative doesn't exclude GI pathology)
- Consider celiac serology (malabsorption)
- Gynecologic evaluation for menstruating women with excessive bleeding
Treatment Protocol
Start oral ferrous iron at 3-6 mg/kg elemental iron daily 2:
- Ferrous sulfate, ferrous gluconate, or ferrous fumarate are equally effective and cost-efficient
- Take on empty stomach for optimal absorption (with vitamin C if tolerated)
- Continue for 3-6 months after hemoglobin normalizes to replete iron stores 7
Expect hemoglobin rise ≥10 g/L within 2 weeks—this response itself confirms iron deficiency even if initial iron studies were equivocal 1.
Common Pitfalls to Avoid
Don't miss thalassemia trait: Inappropriately treating with iron when thalassemia is the cause leads to unnecessary therapy and missed genetic counseling opportunities 4, 8
Don't accept "normal" ferritin in inflammatory states: Ferritin is an acute phase reactant; use 45 μg/L cutoff in chronic disease 1
Don't stop investigating after starting iron: The source of blood loss must be identified to prevent mortality from missed malignancy 1
Don't overlook coexistence: 7% of children with microcytic anemia have both iron deficiency and thalassemia trait 8
Elliptocytes don't change management unless they're the predominant cell type (>25%), which would suggest hereditary elliptocytosis requiring different evaluation 3